We evaluated the analytical characteristics and clinical usefulness of a commercial immunoradiometric assay (IRMA) kit for brain natriuretic peptide (BNP). Mean (+/-SD) plasma BNP concentrations measured in 129 normal subjects were 2.9+/-2.7 pmol/l (median 2.2 pmol/l; range 0.1-12.4 pmol/l). The mean (+/-SD) value observed in healthy men (2.1+/-2.0 pmol/l, n=49) was significantly (p=0.0009) different to that found in women (3.4+/-2.9 pmol/l, n=80). A positive relationship (R=0.214, p=0.0174) was found between BNP values and age; In 65 patients with cardiac diseases, BNP levels increased with the progression of clinical severity of disease; patients with more severe disease [NYHA functional class III-IV, mean (+/-SD) BNP=254+/-408 pmol/l, n=22] showed significantly (p<0.0001) increased values compared to patients with mild symptoms of disease (NYHA functional class I-II, mean (+/-SD) BNP=19.6+/-17.2 pmol/l, n=43). Furthermore, in 32 patients with chronic renal failure, greatly increased (p<0.0001) BNP Values were found both before (mean+/-SD=88.1+/-111.1 pmol/l) and after haemodialysis (mean +/- SD=65.6+/-76.7 pmol/l), with a significant reduction after haemodialysis (p=0.0004) compared to pre-haemodialysis. The mean (+/-SD) BNP value found in atrial extracts collected during aorto-coronary bypass operations in 15 patients was 14.5+/-51.9 pmol/g of cardiac tissue. Moreover, the mean (+/-SD) tissue levels of BNP in 7 heart transplant recipients were 128.4+/-117.2 pmol/g of cardiac tissue in atrium, 68.4+/-76.7 pmol/g in ventricle, and 10.9+/-8.5 pmol/g in interventricular septum. Finally, BNP values found in cardiac tissues of two subjects collected at autopsy were considerably lower (on average 1/1000) than those observed in cardiac tissues of patients with cardiac diseases. The IRMA method for BNP determination evaluated in this study showed a good degree of sensitivity, precision and practicability. Therefore, this method should be a reliable tool for the measurement of plasma BNP levels for both experimental studies and routine assay.
Measurement of brain natriuretic peptide in plasma samples and cardiac tissue extracts by means of an immunoradiometric assay method.
Del Ry S;Clerico A;Giannessi D;Biagini A
2000
Abstract
We evaluated the analytical characteristics and clinical usefulness of a commercial immunoradiometric assay (IRMA) kit for brain natriuretic peptide (BNP). Mean (+/-SD) plasma BNP concentrations measured in 129 normal subjects were 2.9+/-2.7 pmol/l (median 2.2 pmol/l; range 0.1-12.4 pmol/l). The mean (+/-SD) value observed in healthy men (2.1+/-2.0 pmol/l, n=49) was significantly (p=0.0009) different to that found in women (3.4+/-2.9 pmol/l, n=80). A positive relationship (R=0.214, p=0.0174) was found between BNP values and age; In 65 patients with cardiac diseases, BNP levels increased with the progression of clinical severity of disease; patients with more severe disease [NYHA functional class III-IV, mean (+/-SD) BNP=254+/-408 pmol/l, n=22] showed significantly (p<0.0001) increased values compared to patients with mild symptoms of disease (NYHA functional class I-II, mean (+/-SD) BNP=19.6+/-17.2 pmol/l, n=43). Furthermore, in 32 patients with chronic renal failure, greatly increased (p<0.0001) BNP Values were found both before (mean+/-SD=88.1+/-111.1 pmol/l) and after haemodialysis (mean +/- SD=65.6+/-76.7 pmol/l), with a significant reduction after haemodialysis (p=0.0004) compared to pre-haemodialysis. The mean (+/-SD) BNP value found in atrial extracts collected during aorto-coronary bypass operations in 15 patients was 14.5+/-51.9 pmol/g of cardiac tissue. Moreover, the mean (+/-SD) tissue levels of BNP in 7 heart transplant recipients were 128.4+/-117.2 pmol/g of cardiac tissue in atrium, 68.4+/-76.7 pmol/g in ventricle, and 10.9+/-8.5 pmol/g in interventricular septum. Finally, BNP values found in cardiac tissues of two subjects collected at autopsy were considerably lower (on average 1/1000) than those observed in cardiac tissues of patients with cardiac diseases. The IRMA method for BNP determination evaluated in this study showed a good degree of sensitivity, precision and practicability. Therefore, this method should be a reliable tool for the measurement of plasma BNP levels for both experimental studies and routine assay.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


